SectorBiological Technology
Established Date06/09/2019
Listing Date14/01/2022
ExchangeNASDAQ Stock Exchange
Full-time Employees15
Fiscal Year Ends31/12
Security TypeCommon stock
Office address311 West Superior Street, Suite 444, Chicago, IL 60654
Business
IntroductionCardio Diagnostics Holdings, Inc., was incorporated under the laws of the State of Delaware on September 6, 2019. Cardio Diagnostics is a biotechnology company dedicated to making the prevention and early detection of cardiovascular disease more accessible, personalized and precise. Cardio was established to further develop and commercialize a proprietary artificial intelligence-driven integrated genetic-epigenetic EngineTM for cardiovascular disease, becoming one of the leading medical technology companies capable of improving the prevention, early detection and adjuvant treatment of cardiovascular disease.
